William Blair analyst Brandon Vazquez has maintained their neutral stance on NVST stock, giving a Hold rating yesterday.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Brandon Vazquez has given his Hold rating due to a combination of factors influencing Envista Holdings’ current market position. The company reported third-quarter results that exceeded expectations, showing positive trends and effective execution of commercial strategies. Despite these encouraging results, Vazquez notes that the stock’s current valuation already reflects much of this improved performance, as it trades at 17 times the 2026 EPS estimate.
Additionally, while guidance for sales and EPS has been slightly raised, the report suggests that there are still uncertainties that need to be addressed, such as the impact of easy comparisons and deferred benefits. These factors, combined with broader macroeconomic challenges, contribute to the decision to maintain a Hold rating, as the potential for further upside may be limited given the current valuation levels.
Vazquez covers the Healthcare sector, focusing on stocks such as Ceribell, Inc., Align Tech, and Dexcom. According to TipRanks, Vazquez has an average return of -2.9% and a 30.30% success rate on recommended stocks.
In another report released yesterday, TR | OpenAI – 4o also downgraded the stock to a Hold with a $22.00 price target.